Role of fibroblast activation in inducing interstitial fibrosis

Journal of Nephrology

Volumn 13, Issue 3 SUPPL., 2000, Pages

  Zeisberg, Michael ^a   Strutz, Frank ^a   Müller, Gerhard A ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Anti fibrogenic therapy; End stage renal failure (ESRD); Fibroblast; Myofibroblasts; Transforming growth factor ; Tubulointerstitial fibrosis

Indexed keywords

ANIMAL; CHRONIC KIDNEY FAILURE; FIBROBLAST; FIBROSIS; HUMAN; KIDNEY; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; SMOOTH MUSCLE;

ANIMALS; FIBROBLASTS; FIBROSIS; HUMANS; KIDNEY; KIDNEY FAILURE, CHRONIC; MUSCLE, SMOOTH;

EID: 0034323610     PISSN: 11218428     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Strutz F, Muller GA. Interstitial pathomechanisms underlying progressive tubulointerstitial damage. Kidney Blood Press Res 1999; 22: 71-80.
2. Pastan S, Bailey J. Dialysis therapy [see comments]. N Engl J Med 1998; 338: 1428-37.
3. Brenner BM, Meyer TW, Hostetter TH. Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease. N Engl J Med 1982; 307: 652-9.
4. Bohle A, Christ H, Grund KE, Mackensen S. The role of the interstitium of the renal cortex in renal disease. Contrib Nephrol 1979; 16: 109-14.
5. Frei U, Schober-Halstenberg HJ. Annual Report of the German Renal Registry 1998. QuaSi-Niere Task Group for Quality Assurance in Renal Replacement Therapy. Nephrol Dial Transplant 1999; 14: 1085-90.
6. Bohle A, Wehrmann M, Bogenschutz O. The long-term prognosis of the primary glomerulonephritides. A morphological and clinical analysis of 1747 cases. Pathol Res Pract 1992; 188: 908-24.
7. Mutsaers SE, Bishop JE, McGrouther G, Laurent GJ. Mechanisms of tissue repair: from wound healing to fibrosis. Int J Biochem Cell Biol 1997; 29: 5-17.
8. Strutz F, Muller GA. On the progression of chronic renal disease. Nephron 1995; 69: 371-9.
9. Kuncio GS, Neilson EG, Haverty T. Mechanisms of tubulointerstitial fibrosis. Kidney Int 1991; 39: 550-6.
10. Lemley KV, Kriz W. Anatomy of the renal interstitium. Kidney Int 1991; 39: 370-81.
11. Gharaee-Kermani M, Wiggins R, Wolber F, Goyal M, Phan SH. Fibronectin is the major fibroblast chemoattractant in rabbit anti- glomerular basement membrane disease. Am J Pathol 1996; 148: 961-7.
12. Nadasdy T, Laszik Z, Blick KE, Johnson DL, Silva FG. Tubular atrophy in the end-stage kidney: a lectin and immunohisto-chemical study. Hum Pathol 1994; 25: 22-8.
13. Ng YY, Huang TP, Yang WC. Tubular epithelial-myofibroblast transdifferentiation in progressive tubulointerstitial fibrosis in 5/6 nephrectomized rats. Kidney Int 1998; 54: 864-76.
14. Eddy AA. Molecular insights into renal interstitial fibrosis [editorial]. J Am Soc Nephrol 1996; 7: 2495-508.
15. Razzaque MS, Harada T, Taguchi T. Distribution and cellular origin of type III, type IV and type VI collagens in tubulointerstitial damage in various renal diseases [letter]. Clin Nephrol 1996; 46: 213-5.
16. Kootstra CJ, Bergijk EC, Veninga A. Qualitative alterations in laminin expression in experimental lupus nephritis. Am J Pathol 1995; 147: 476-88.